130 related articles for article (PubMed ID: 27502789)
1. Posterior subtenon injection of triamcinolone acetonide for pseudophakic cystoid macular oedema.
Tsai MJ; Yang CM; Hsieh YT
Acta Ophthalmol; 2018 Nov; 96(7):e891-e893. PubMed ID: 27502789
[No Abstract] [Full Text] [Related]
2. Comparison of Subtenon Triamcinolone Acetonide Injection with Topical Nepafenac for the Treatment of Pseudophakic Cystoid Macular Edema.
Yüksel B; Uzunel UD; Kerci SG; Sağban L; Küsbeci T; Örsel T
Ocul Immunol Inflamm; 2017 Aug; 25(4):513-519. PubMed ID: 27015572
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal triamcinolone for macular oedema: efficacy in relation to aetiology.
Sørensen TL; Haamann P; Villumsen J; Larsen M
Acta Ophthalmol Scand; 2005 Feb; 83(1):67-70. PubMed ID: 15715560
[TBL] [Abstract][Full Text] [Related]
4. Posterior subtenon injection of triamcinolone acetonide after phacoemulsification in a patient with X-linked retinoschisis.
Wang JK; Lin WC
Optom Vis Sci; 2013 Oct; 90(10):e274-7. PubMed ID: 23974665
[TBL] [Abstract][Full Text] [Related]
5. Intraocular triamcinolone acetonide for pseudophakic cystoid macular edema: optical coherence tomography and multifocal electroretinography study.
Koutsandrea C; Moschos MM; Brouzas D; Loukianou E; Apostolopoulos M; Moschos M
Retina; 2007 Feb; 27(2):159-64. PubMed ID: 17290196
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal versus posterior subtenon injection of triamcinolone acetonide for diabetic macular edema.
Choi YJ; Oh IK; Oh JR; Huh K
Korean J Ophthalmol; 2006 Dec; 20(4):205-9. PubMed ID: 17302204
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal and posterior subtenon triamcinolone acetonide in idiopathic bilateral uveitic macular oedema.
Choudhry S; Ghosh S
Clin Exp Ophthalmol; 2007 Nov; 35(8):713-8. PubMed ID: 17997773
[TBL] [Abstract][Full Text] [Related]
8. Effect of Posterior Subtenon Triamcinolone Acetonide Injection on Diabetic Macular Edema Refractory to Intravitreal Bevacizumab Injection.
Kim MW; Moon H; Yang SJ; Joe SG
Korean J Ophthalmol; 2016 Feb; 30(1):25-31. PubMed ID: 26865800
[TBL] [Abstract][Full Text] [Related]
9. Steroid hypopyon following intravitreal triamcinolone acetonide injection in a pseudophakic patient.
Amato JE; Lee DH; Santos BA; Akduman L
Ocul Immunol Inflamm; 2005; 13(2-3):245-7. PubMed ID: 16019686
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
Patel PJ; Zaheer I; Karia N
Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Analysis of Uveitis Macular Edema in Multiple Sclerosis Patients Receiving Deep Posterior Sub-Tenon Triamcinolone Acetonide Injection.
Jovanović S; Šarenac Vulović T; Radotić F; Tončić Z; Živković M; Petrović N
Ophthalmic Res; 2017; 58(1):1-7. PubMed ID: 28324879
[TBL] [Abstract][Full Text] [Related]
12. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G
Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840
[TBL] [Abstract][Full Text] [Related]
13. The Efficacy of Posterior Subtenon Triamcinolone Acetonide Injection in Treatment of Irvine-Gass Syndrome.
Erden B; Çakır A; Aslan AC; Bölükbaşı S; Elçioğlu MN
Ocul Immunol Inflamm; 2019; 27(8):1235-1241. PubMed ID: 31411519
[No Abstract] [Full Text] [Related]
14. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.
Bae JH; Lee CS; Lee SC
Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170
[TBL] [Abstract][Full Text] [Related]
15. A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion.
Cekiç O; Cakır M; Yazıcı AT; Alagöz N; Bozkurt E; Faruk Yılmaz O
Curr Eye Res; 2010 Oct; 35(10):925-9. PubMed ID: 20858114
[TBL] [Abstract][Full Text] [Related]
16. Reduction in the frequency of intravitreal bevacizumab administrations achieved by posterior subtenon injection of triamcinolone acetonide in patients with diffuse diabetic macular edema.
Shimura M; Yasuda K; Minezaki T; Noma H
Jpn J Ophthalmol; 2016 Sep; 60(5):401-7. PubMed ID: 27306783
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal triamcinolone acetonide for patients with macular oedema due to central retinal vein occlusion in Taiwan.
Cheng KC; Wu WC; Lin CJ
Eye (Lond); 2009 Apr; 23(4):849-57. PubMed ID: 18535613
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.
Sheth S; Rush R; Natarajan S; Gillies M
Clin Exp Ophthalmol; 2011; 39(7):673-81. PubMed ID: 22452685
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal triamcinolone acetonide for the management of papillophlebitis and associated macular edema.
Chang YC; Wu WC
Int Ophthalmol; 2008 Aug; 28(4):291-6. PubMed ID: 17701380
[TBL] [Abstract][Full Text] [Related]
20. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
